AKT/AMPK-mediated phosphorylation of TBC1D4 disrupts the interaction with insulin-regulated aminopeptidase.
AMP-Activated Protein Kinases
/ genetics
Aminopeptidases
/ genetics
Animals
GTPase-Activating Proteins
/ genetics
Gene Expression Regulation, Enzymologic
/ drug effects
Hypoglycemic Agents
/ pharmacology
Insulin
/ pharmacology
Mice
Mice, Inbred C57BL
Muscle, Skeletal
/ drug effects
Phosphorylation
Proto-Oncogene Proteins c-akt
/ genetics
Akt PKB
GTPase-activating protein (GAP)
Rab10
glucose transporter type 4 (GLUT4)
insulin-regulated aminopeptidase (IRAP)
protein phosphorylation
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
Historique:
received:
28
01
2021
revised:
29
03
2021
accepted:
05
04
2021
pubmed:
20
4
2021
medline:
24
8
2021
entrez:
19
4
2021
Statut:
ppublish
Résumé
TBC1D4 is a 160 kDa multidomain Rab GTPase-activating protein (RabGAP) and a downstream target of the insulin- and contraction-activated kinases AKT and AMPK. Phosphorylation of TBC1D4 has been linked to translocation of GLUT4 from storage vesicles (GSVs) to the cell surface. However, its impact on enzymatic activity is not well understood, as previous studies mostly investigated the truncated GAP domain lacking the known phosphorylation sites. In the present study, we expressed and purified recombinant full-length TBC1D4 using a baculovirus system. Size-exclusion chromatography and coimmunoprecipitation experiments revealed that full-length TBC1D4 forms oligomers of ∼600 kDa. Compared with the truncated GAP domain, full-length TBC1D4 displayed similar substrate specificity, but had a markedly higher specific GAP activity toward Rab10. Using high-resolution mass spectrometry, we mapped 19 Ser/Thr phosphorylation sites in TBC1D4. We determined Michaelis-Menten kinetics using in vitro phosphorylation assays with purified kinases and stable isotope-labeled γ-[
Identifiants
pubmed: 33872597
pii: S0021-9258(21)00423-3
doi: 10.1016/j.jbc.2021.100637
pmc: PMC8131924
pii:
doi:
Substances chimiques
GTPase-Activating Proteins
0
Hypoglycemic Agents
0
Insulin
0
Tbc1d4 protein, mouse
0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
AMP-Activated Protein Kinases
EC 2.7.11.31
Aminopeptidases
EC 3.4.11.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100637Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare no conflicts of interest in regard to this article.